Prevention of nephritis in major histocompatibility complex class II-deficient MRL-lpr mice.
Authors:
Open Access
- 1 April 1994
- journal article
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 179 (4) , 1137-1143
Abstract
MRL-lpr mice develop aggressive autoimmune kidney disease associated with increased or de novo renal expression of major histocompatibility complex (MHC) class II molecules and a massive systemic expansion of CD4-CD- double negative (DN) T cells. Whereas non-MHC linked genes can have a profound effect on the development of nephritis, lymphadenopathy, and anti-DNA antibody production in MRL-lpr mice, the role of MHC molecules has not been unequivocally established. To study the role of MHC class II in this murine model of systemic lupus erythematosis, class II-deficient MRL-lpr mice (MRL-lpr -/-) were created. MRL-lpr -/- mice developed lymphadenopathy but not autoimmune renal disease or autoantibodies. This study demonstrates that class II expression is critical for the development of autoaggressive CD4+ T cells involved in autoimmune nephritis and clearly dissociates DN T cell expansion from autoimmune disease initiation.Keywords
This publication has 29 references indexed in Scilit:
- Origin of CD4-CD8-B220+ T cells in MRL-lpr/lpr mice. Clues from a T cell receptor beta transgenic mouseThe Journal of Immunology, 1993
- B lymphocyte development and activation independent of MHC class II expressionThe Journal of Immunology, 1993
- Genetic analysis of MRL-lpr mice: relationship of the Fas apoptosis gene to disease manifestations and renal disease-modifying loci.Journal of Experimental Medicine, 1992
- Autoreactive kidney-infiltrating T-cell clones in murine lupus nephritisKidney International, 1992
- Prevention of lymphadenopathy in MRL-lpr/lpr mice by blocking peripheral lymph node homing with Mel-14 in vivo.The Journal of Immunology, 1988
- Reactive lymphocytes in lacrimal gland and vasculitic renal lesions of autoimmune MRL/lpr mice express L3T4.Journal of Experimental Medicine, 1987
- CS-A therapy in MRL-lpr/lpr mice: amelioration of immunopathology despite autoantibody production.The Journal of Immunology, 1987
- Clonal diversity and T-cell receptor beta-chain variable gene expression in enlarged lymph nodes of MRL-lpr/lpr lupus mice.Proceedings of the National Academy of Sciences, 1986
- Induction of various autoantibodies by mutant gene lpr in several strains of mice.The Journal of Immunology, 1984
- Etiopathogenesis of Murine SLE1Immunological Reviews, 1981